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CASE REPORT
A 65-year-old woman, with a history of type II diabetes and
high blood pressure, was admitted for diverticulitis. Clinical
examination showed a central obesity and a moon face.
Neurological examination did not reveal any abnormality.
Endocrine studies revealed Cushing’s syndrome with an increase
of urinary free cortisol at 1578nmol/24h (normal values: 30-220
nmol/24h), and a midnight salivary cortisol at 23.53 nmol/l
(normal value at midnight: <6.1 nmol/l ). Adrenocorticotropic
hormone (ACTH) was increased at 71 ng/l (normal value: 10-60
ng/l), the high dose dexamethasone suppression test (8mg) and
the corticotropin releasing hormone (CRH) test were consistent
with Cushing’s disease. Indeed we noticed a cortisol suppression
in response to the high dose test and not to the low dose
dexamethasone test. There was also a significant increase of
ACTH and cortisol following intravenous administration of a
CRH bolus. Clinico-biological status suggested a diagnosis of
Cushing’s disease. Magnetic resonance imaging (MRI) and
computed tomography (CT) (Figure 1), revealed a calcified
intrasellar mass, extending to the suprasellar space, without
invasion of the optic pathways or cavernous sinus. This mass
appeared heterogeneously hypointense in T1 and T2 weighted-
images (wi). The periphery of the mass was slightly hyperintense
in T1 and T2 wi with an enhancement after gadolinium
administration (Figure 2). In addition petrosal sinus sampling
was performed, showing an abnormal ACTH secretion in the left
side. Investigations suggested a largely calcified pituitary
macroadenoma; also named pituitary stone. The hyperintense
enhanced peripheral zone corresponds to non-calcified adenoma
tissue.
Trans-sphenoidal hemi-hypophysectomy, taking the calcified
area, was performed. The histological study confirmed a
calcified pituitary macroadenoma with a strong immuno-
cytochemistry expression of ACTH within the calcified area;
ACTH positivity was also noted in the surrounding tissue.
The post-operative course was uneventful and the Cushing’s
syndrome resolved.
DISCUSSION
Calcified sellar lesions are rare.1 The differential diagnosis
includes: craniopharyngioma, pituitary adenoma, Rathke cleft
cyst, meningioma and chordoma.1,2 Craniopharygioma is the
most common diagnosis.3
There are mainly two types of calcifications: capsular
curvilinear calcifications and nodular central calcifications. The
nodular pattern suggests craniopharyngioma and the curvilinear
pattern suggests pituitary adenoma (Figure 1 and 2) or rarely a
calcified Rathke cleft cyst.2,3
Calcifications are present in 15-25% of pituitary adenoma.4
The calcifications are radiologically detected in 0.2 to 14% of
cases.5,6 Largely calcified pituitary adenomas are very rare (see
video on-line).6
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Figure 1: CT image in a coronal view, centred on the sellar space and
showing a largely calcified sellar mass.
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Calcification in adenomatous tissus could be secondary to
necrosis during silent pituitary apoplexy. In fact, old bleeding
was found around and inside the calcified adenomas.6 It may
appear following a bromocriptine treatment or radiation therapy.7
Calcifications are most common in prolactin pituitary
adenomas,1,7,8 and very rare in corticotroph.9 The first
corticotroph pituitary stone was reported in 1989 with a
spontaneous resolution of a Cushing’s disease. Authors supposed
that the large calcifications destroyed the ACTH-producing
tissue.9
An amyloid deposition is present in 71% of the pituitary
adenoma, probably related to the peptide-hormonal synthesis
process and the degenerative changes of the tumor. The amyloid
deposition occurs commonly with a stellar-perivascular
distribution and rarely with a spherical presentation. The
spherical presentation appears almost exclusively in prolactin
adenoma, and can appear as high density spots on CT, simulating
an extensive calcified pituitary adenoma.10
The treatment of choice of pituitary adenoma is surgery.
Transsphenoidal approach showed excellent results regarding
safety and efficacy. The success of this approach depends on
many factors, including the size, the location, the subtype, the
invasiveness and the histopathological markers of the tumor.11
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Figure 2: a) coronal T2 wi. b) coronal T1 wi. c) sagittal T1 wi. without contrast administration d) sagittal T2 wi.
without contrast administration. MRI images centred on the sellar space showing a heterogeneously hypointense
mass in T1 and T2 wi. The periphery of the mass appears slightly hyperintense in T1 and T2 wi with an
enhancement after gadolinium administration.
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